Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
3.02 USD -3.21% Intraday chart for NeuroBo Pharmaceuticals, Inc. -11.18% -18.30%
Apr. 17 Sector Update: Health Care Stocks Mixed Wednesday Afternoon MT
Apr. 17 NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise MT

Evolution of the average Target Price on NeuroBo Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

46a23fb060.aYMVMx5aJ8-ZRrEWcGdu6NOE0SonId270eRGLgnLj8w.W85abE00cIzNEeElHRclvYflpwdOSYTVsIVxX2yDyoAB2jhGTg9_juMM-A~ece593000929998dcacc7e8510f7d26e

Analyst Recommendations on NeuroBo Pharmaceuticals, Inc.

Ladenburn Thalmann Starts NeuroBo Pharmaceuticals at Buy With $6 Price Target MT
NEUROBO PHARMACEUTICALS : HC Wainwright Adjusts Price Target on NeuroBo Pharmaceuticals to $16 From $20, Reiterates Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.02 USD
Average target price
36.5 USD
Spread / Average Target
+1,108.61%
High Price Target
48 USD
Spread / Highest target
+1,489.40%
Low Price Target
25 USD
Spread / Lowest Target
+727.81%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NeuroBo Pharmaceuticals, Inc.

Ladenburg Thalmann
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. Consensus NeuroBo Pharmaceuticals, Inc.